NEWS: 公告在东京证券交易所JASDAQ标准市场新上市

表纸
市场调查报告书

淋菌感染疾病 - 全球临床试验检讨

Neisseria gonorrhoeae Infections - Global Clinical Trials Review, H2, 2020

出版商 GlobalData 商品编码 979351
出版日期 内容资讯 英文 184 Pages
订单完成后即时交付
价格
淋菌感染疾病 - 全球临床试验检讨 Neisseria gonorrhoeae Infections - Global Clinical Trials Review, H2, 2020
出版日期: 2020年12月16日内容资讯: 英文 184 Pages
简介

本报告提供全球淋菌感染疾病的临床试验调查分析,提供临床试验方案概要,临床实验数,平均登记数,加上全球临床实验形势,主要资料,主要企业等相关的系统性资讯。

目录

目录

  • 指导
  • 调查范围
  • 临床试验:各地区
  • 临床实验数和平均登记数:各国
  • 亚太地区对临床试验有贡献的前五名国家
  • 欧洲对临床试验有贡献的前五名国家
  • 北美对临床试验有贡献的前几名国家
  • 中东·非洲对临床试验有贡献的前五名国家
  • 临床试验:G7各国 - 感染疾病的临床试验上淋菌感染疾病的比例
  • 临床试验:G7各国的不同阶段
  • G7各国的临床试验:各临床实验状态
  • 临床试验:E7各国 - 感染疾病的临床试验上淋菌感染疾病的比例
  • 临床试验:E7各国的不同阶段
  • E7各国的临床试验:各临床实验状态
  • 临床试验:不同阶段
  • 进行中的临床实验:不同阶段
  • 临床试验:各临床实验状态
  • 临床试验:各评估项目状态
  • 一定期间所募集的受验人数
  • 临床试验:各赞助商类型
  • 有力的赞助商
  • 参加淋菌感染疾病治疗临床试验的主要企业
  • 有力的医药品
  • 临床试验简介的概述

附录

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: GDHC6543CTIDB

GlobalData's clinical trial report, "Neisseria gonorrhoeae Infections - Global Clinical Trials Review, H2, 2020" provides an overview of Neisseria gonorrhoeae Infections Clinical trials scenario. This report provides top line data relating to the clinical trials on Neisseria gonorrhoeae Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

List of Tables

List of Figures

  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Neisseria gonorrhoeae Infections to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Neisseria gonorrhoeae Infections to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Neisseria gonorrhoeae Infections Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Source

List of Tables

List of Tables

  • Neisseria gonorrhoeae Infections Therapeutics, Global, Clinical Trials by Region, 2020*
  • Neisseria gonorrhoeae Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Neisseria gonorrhoeae Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Neisseria gonorrhoeae Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020*
  • Neisseria gonorrhoeae Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2020*
  • Neisseria gonorrhoeae Infections Therapeutics Clinical Trials, North America, Top Countries, 2020*
  • Neisseria gonorrhoeae Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2020*
  • Proportion of Neisseria gonorrhoeae Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2020*
  • Neisseria gonorrhoeae Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Neisseria gonorrhoeae Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Neisseria gonorrhoeae Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2020*
  • Neisseria gonorrhoeae Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Neisseria gonorrhoeae Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Neisseria gonorrhoeae Infections Therapeutics, Global, Clinical Trials by Phase, 2020*
  • Neisseria gonorrhoeae Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2020*
  • Neisseria gonorrhoeae Infections Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Neisseria gonorrhoeae Infections Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Neisseria gonorrhoeae Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Neisseria gonorrhoeae Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020*
  • Neisseria gonorrhoeae Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Neisseria gonorrhoeae Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Neisseria gonorrhoeae Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*

List of Figures

List of Figures

  • Neisseria gonorrhoeae Infections Therapeutics, Global, Clinical Trials by Region (%), 2020*
  • Neisseria gonorrhoeae Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Neisseria gonorrhoeae Infecti